Ebook Endoscopy in liver disease: Part 2
➤ Gửi thông báo lỗi ⚠️ Báo cáo tài liệu vi phạmNội dung chi tiết: Ebook Endoscopy in liver disease: Part 2
Ebook Endoscopy in liver disease: Part 2
I’7311Colonoscopic Screening and Surveillance in the Patient with Liver Disease (Including Post-Transplant)William M. Tierney' and Khadija Chaudrey2' Ebook Endoscopy in liver disease: Part 2 Professor ofMedKVK Dyestive Diseases and Nvtnnon Section, Uiwersrtyof Oklahoma Health Sciences Center. Oklahoma City. OkJaboma. USA3 Gastroenterologist. Division of Gastroenterology and Hepatology, Mayo Clinic. Rochester. Minnesota. USAIntroductionPatients with liver disease and expected long term Ebook Endoscopy in liver disease: Part 2survival warrant standard health maintenance screening to promote health. On the other hand, patients with advanced cirrhosis who are not candidates fEbook Endoscopy in liver disease: Part 2
or transplantation may have limited survival and may thus not be suitable for routine health screening. This may be especially true for screening withI’7311Colonoscopic Screening and Surveillance in the Patient with Liver Disease (Including Post-Transplant)William M. Tierney' and Khadija Chaudrey2' Ebook Endoscopy in liver disease: Part 2patients without serious extrahepatic disease that would limit life expectancy or complicate the post-transplant course. Colonoscopy for colorectal cancer (CRC) screening or surveillance for adenomatous polyps falls into this category of health screens that warrants selective and thoughtful applicat Ebook Endoscopy in liver disease: Part 2ion in patients with liver disease. Some liver diseases, such as primary sclerosing cholangitis (PSC) with associated colitis, are known risk factorsEbook Endoscopy in liver disease: Part 2
for CRC and deserve special consideration [1,2]. This chapter outlines and discusses the colonoscopic screening and surveillance guidelines thatapply I’7311Colonoscopic Screening and Surveillance in the Patient with Liver Disease (Including Post-Transplant)William M. Tierney' and Khadija Chaudrey2' Ebook Endoscopy in liver disease: Part 2t common cancer in the USA and the second leading cause of cancer death [3]. CRC screening and surveillance are effective and have consistently been shown to reduce CRC related morbidity and mortality. Prevention and early detection of CRC in screening populations have led to decreased incidence and Ebook Endoscopy in liver disease: Part 2 death rates. In the recent report to the nation on the status of cancer covering 1975-2006, overall cancer death rates continued to decline in the USEbook Endoscopy in liver disease: Part 2
A among both men and women, and in all major racial and ethnic groups; this decline was most prominent for CRC [4]. This has been attributed to risk fI’7311Colonoscopic Screening and Surveillance in the Patient with Liver Disease (Including Post-Transplant)William M. Tierney' and Khadija Chaudrey2' Ebook Endoscopy in liver disease: Part 2USPSTF), and the American College of Gastroenterology (ACG) have all formulated colonEmtosco/ry ót Liver Disease. First Edition. Edited by lohn N. Plevris. Peter c. Hayes, Patrick s. Kamath. and Louis M Wong Kcv Song. © 2018 John Wiley & Sons Ltd. Published 2018 by John Wiley & Sons Ltd.Companion we Ebook Endoscopy in liver disease: Part 2bsite: WWW wilcy-conb'goi'plcvris.'endoscopyinliverdiseasc174 Colonoscopic Screening and Surveillance in the Patient with Liver Disease (Including PosEbook Endoscopy in liver disease: Part 2
t-Transplant)cancer screening guidelines [6-8]. While there are variations between the guidelines, there is general consensus that one of the various I’7311Colonoscopic Screening and Surveillance in the Patient with Liver Disease (Including Post-Transplant)William M. Tierney' and Khadija Chaudrey2' Ebook Endoscopy in liver disease: Part 2 the most rigorous data from randomized controlled trials exist for fecal occult blood testing and flexible sigmoidoscopy, there is a growing body of case-control data suggesting that screening colonoscopy reduces CRC mortality [9-17]. In the USA, colonoscopy has become the dominant form of CRC scre Ebook Endoscopy in liver disease: Part 2ening in average risk individuals, although overall screening rates remain low relative to other types of cancer screening [18]. In the UK, 2-yearly fEbook Endoscopy in liver disease: Part 2
ecal occult blood testing from the age of 50 years (Scotland) or 55 years (England) followed by colonoscopy for positive testing is the dominant form I’7311Colonoscopic Screening and Surveillance in the Patient with Liver Disease (Including Post-Transplant)William M. Tierney' and Khadija Chaudrey2' Ebook Endoscopy in liver disease: Part 2nting CRC. Based on the National Polyp Study, patients with adenomatous polyps have a reduced incidence of CRC after polypectomy. Patients found to have adenomas are at increased risk for developing metachronous adenomas or cancer compared with patients without adenomas [19]. Therefore, once adenoma Ebook Endoscopy in liver disease: Part 2s are detected, patients are advised to have colonoscopic surveillance and the US MSTF on CRC has proposed post-polypectomy surveillance intervals basEbook Endoscopy in liver disease: Part 2
ed on polyp number and characteristics. Recommended screening and surveillance intervals are based on evidence showing that periodic examinations reduI’7311Colonoscopic Screening and Surveillance in the Patient with Liver Disease (Including Post-Transplant)William M. Tierney' and Khadija Chaudrey2' Ebook Endoscopy in liver disease: Part 2-Societyof GastroenterologyUS Preventive Services Task ForceEbook Endoscopy in liver disease: Part 2
y 5 yearsCancer detection testsFecal immunochemical test (FIT)Annual (preferred)AnnualAnnualHighly sensitive guaiac based fecal occult blood test (gFOI’7311Colonoscopic Screening and Surveillance in the Patient with Liver Disease (Including Post-Transplant)William M. Tierney' and Khadija Chaudrey2' Ebook Endoscopy in liver disease: Part 2ectal neoplasia.’ The ACG recommends screening the African American population at age 45 years.' Screening for individuals aged 76-85 years can be considered on an individual basis but is not routinely recommended, while individuals older than 85 should not undergo screening.I'75Bowel Preparation in Ebook Endoscopy in liver disease: Part 2 Patienti with Ltver DiieaieTable 11.2 United States Multi-Society Task Force 2012 surveillance recommendations [6].I’7311Colonoscopic Screening and Surveillance in the Patient with Liver Disease (Including Post-Transplant)William M. Tierney' and Khadija Chaudrey2' I’7311Colonoscopic Screening and Surveillance in the Patient with Liver Disease (Including Post-Transplant)William M. Tierney' and Khadija Chaudrey2'Gọi ngay
Chat zalo
Facebook